Miao Shao

Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial

Jing He, Ruijun Zhang, Miao Shao et al. · Annals of the Rheumatic Diseases · 2019 · 337 citations · Full text

Life Sciences, Immunology, Autoimmunity +9

Efficacy and Safety of Low-Dose Interleukin 2 for Primary Sjögren Syndrome

Jing He, Jiali Chen, Miao Miao et al. · JAMA Network Open · 2022 · 88 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Efficacy and safety of low-dose interleukin-2 in combination with methotrexate in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase 2 trial

Xiaoying Zhang, Miao Miao, Ruijun Zhang et al. · Signal Transduction and Targeted Therapy · 2022 · 69 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Predictors of Poor Outcome of Anti‐MDA5‐Associated Rapidly Progressive Interstitial Lung Disease in a Chinese Cohort with Dermatomyositis

Yuhui Li, Yimin Li, Jian Wu et al. · Journal of Immunology Research · 2020 · 66 citations · Full text

Life Sciences, Dermatology, Immunology +17

Double Negative B Cell Is Associated With Renal Impairment in Systemic Lupus Erythematosus and Acts as a Marker for Nephritis Remission

Xujie You, Ruijun Zhang, Miao Shao et al. · Frontiers in Medicine · 2020 · 52 citations · Full text

Life Sciences, Immunology, Nephrology +17